Fibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers from Yale’s Section of Pulmonary, Critical Care and Sleep Medicine have used single-cell sequencing technology to provide the first high-resolution atlas of this disease, revealing a previously unrecognized immune signature. Their findings were recently published in the American Journal of Respiratory and Critical Care Medicine.

In a Q&A, Changwan "Wonnie" Ryu, MD, MPH, who recently won the ASCI Council Young Physician-Scientist Award, discusses the role of innate immunity in the development of idiopathic pulmonary fibrosis, his goal as a physician-scientist, and the inspiration behind his work.

Herzog's laboratory has had a sustained impact on the field of pulmonary fibrosis and is credited with providing new insight into convergent and divergent mechanisms existing at the interface of lung injury and repair. She also is a dedicated clinician.

Members of Pulmonary, Critical Care & Sleep Medicine (Yale-PCCSM) at Yale School of Medicine were honored during the American Thoracic Society (ATS) 2022 International Conference in San Francisco.

The Department of Internal Medicine is pleased to announce the following seven faculty recently promoted to/named rank of professor.

Sarwat Chaudhry, MD, and Erica Herzog, MD, PhD, will lead the Office of Student Research (OSR) as associate deans, effective January 1, 2020. They will succeed John N. Forrest Jr, MD, professor of medicine, who has led OSR since it was established in 1986.